Researchers assessed clinical features, muscle biopsy scores, and myositis-specific antibody profiles in juvenile dermatomyositis, and their association with disease outcomes and treatment responses in patients.
Researchers aimed to evaluate the feasibility of studying creatine in juvenile dermatomyositis and to determine the effect of creatine on muscle function and metabolism.
Study authors investigated the link between anti-P155/140 and lipodystrophy, and between anti-P155/140 and damage to the nailfold capillary system in children with juvenile dermatomyositis.
Researchers investigated the content validity of patient-reported outcome measures in patients with idiopathic inflammatory myopathies.
Experts highlight the need for cancer screening strategies in patients with rheumatic diseases.
Researchers determined whether a modified disease activity score (DAS) correlated with the validated DAS in patients with juvenile dermatomyositis.
Researchers studied growth and puberty in a multinational prospective cohort of children with juvenile dermatomyositis.
Researchers analyzed endothelial biomarker levels in the peripheral blood of patients with juvenile dermatomyositis and their association with disease assessments.
Researchers measured discordance between patient or family and physician global activity scores in juvenile dermatomyositis, and determined factors associated with discordance.
Muscle disease is more prominent among patients with dermatomyositis and anti-Mi2 autoantibodies compared with in those who have anti-Mi2-negative dermatomyositis.
